Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

NCT01419704 is registered in ClinicalTrials.gov with Talaris Therapeutics Inc. as lead sponsor.

NCT NCT01419704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01419704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Lead sponsor
Talaris Therapeutics Inc.
Phase
Phase 1/2
Overall status
Withdrawn
Start date
May 31, 2011
Completion date
May 31, 2016
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-thalassemia, anemia, sickle cell, beta-thalassemia, bone marrow failure syndromes, complex and transfusion-dependent hemoglobinopathies, diamond-blackfan anemia, thalassemia